← FDA Drug Approvals (Drugs@FDA)
XENLETA
NDA · New Drug Application · Sponsor: HONG KONG · Approved 2019-08-19
Drug application
- FDA Application #
NDA211672- Application type
- New Drug Application
- Brand name
- XENLETA
- Generic name
- Lefamulin Acetate
- Active ingredients
- LEFAMULIN ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HONG KONG
- First approval
- 2019-08-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown